SAP-001 clinical trials
Also written SAP-001.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2018
How each study uses SAP-001 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- SAP-001
- 5
Studies by the year they started
5 studies that test it; most in 2018 (1)
| Year | Studies |
|---|---|
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 0
Studies
Open first, then newest update. How each study uses SAP-001 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- PK and Safety Evaluation Study of SAP-001 in Adult Subjects With Normal and Impaired Renal FunctionActive, not recruitingPhase 1/2Shanton Pharma Pte. Ltd.NCT06729853Written as SAP-001
- Dose Finding Study to Evaluate Safety and Efficacy of 3 Dosages of SAP 001.Active, not recruitingPhase 2Shanton Pharma Pte. Ltd.NCT05690204Written as SAP-001
- SAD,MAD and Food Effect Study of SAP-001 Tablets in Chinese SubjectsCompletedPhase 1Shanton Pharma Co., Ltd.NCT06678581Written as SAP-001
- Placebo Controlled, Multiple Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAP-001 in Gout PatientsCompletedPhase 2Shanton Pharma Co., Ltd.NCT04040816Written as SAP-001
- Placebo Controlled, Dose Escalation Study to Evaluate Safety, Pharmacokinetics & Efficacy of SAP-001 in Gout PatientsCompletedPhase 1Shanton Pharma Co., Ltd.NCT03857165Written as SAP-001